These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7848120)

  • 21. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.
    Cull RE; Price WH; Dunbar A
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):490-5. PubMed ID: 9153607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interictal "patchy" regional cerebral blood flow patterns in migraine patients. A single photon emission computerized tomographic study.
    Friberg L; Olesen J; Iversen H; Nicolic I; Sperling B; Lassen NA; Olsen TS; Tfelt-Hansen P
    Eur J Neurol; 1994 Sep; 1(1):35-43. PubMed ID: 24283427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine.
    Limmroth V; May A; Auerbach P; Wosnitza G; Eppe T; Diener HC
    J Neurol Sci; 1996 Jun; 138(1-2):60-5. PubMed ID: 8791240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
    Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
    Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exteroceptive suppression of temporalis muscle activity during migraine attack and migraine interval before and after treatment with sumatriptan.
    Göbel H; Krapat S; Dworschak M; Heuss D; Ensink FB; Soyka D
    Cephalalgia; 1994 Apr; 14(2):143-8. PubMed ID: 8062353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan.
    Dowson AJ; Massiou H; Aurora SK
    J Headache Pain; 2005 Apr; 6(2):81-7. PubMed ID: 16362647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.
    Färkkilä M; Olesen J; Dahlöf C; Stovner LJ; ter Bruggen JP; Rasmussen S; Muirhead N; Sikes C
    Cephalalgia; 2003 Jul; 23(6):463-71. PubMed ID: 12807526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice.
    Russell MB; Holm-Thomsen OE; Rishøj Nielsen M; Cleal A; Pilgrim AJ; Olesen J
    Cephalalgia; 1994 Aug; 14(4):291-6. PubMed ID: 7954759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
    Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
    Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan.
    Rapoport AM; Visser WH; Cutler NR; Alderton CJ; Paulsgrove LA; Davis RL; Ferrari MD
    Neurology; 1995 Aug; 45(8):1505-9. PubMed ID: 7644049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced efficacy of sumatriptan in migraine with aura vs without aura.
    Hansen JM; Goadsby PJ; Charles A
    Neurology; 2015 May; 84(18):1880-5. PubMed ID: 25841032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography.
    Lauritzen M; Olesen J
    Brain; 1984 Jun; 107 ( Pt 2)():447-61. PubMed ID: 6609739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral sumatriptan for the long-term treatment of migraine: clinical findings.
    Rederich G; Rapoport A; Cutler N; Hazelrigg R; Jamerson B
    Neurology; 1995 Aug; 45(8 Suppl 7):S15-20. PubMed ID: 7644080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.
    Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ
    Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional cerebral blood flow and oxygen metabolism during migraine with and without aura.
    Andersson JL; Muhr C; Lilja A; Valind S; Lundberg PO; Långström B
    Cephalalgia; 1997 Aug; 17(5):570-9. PubMed ID: 9251871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.